glp-1 drug mounjaro Use of the dual GIP/GLP-1 tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with drugs among patients with type 2 diabetes, a large retrospective cohort GLP-1 Drug Overdose

Nutritional deficiency concerns specifically: With reduced appetite and smaller meals, people may not meet their micronutrient targets (vitamins A, D, B-complex, minerals like magnesium, zinc, etc)

The Medicare GLP-1 Bridge program launching in July 2026 will provide access to Wegovy, Zepbound, and Foundayo at just $50 per month for eligible beneficiaries through the end of 2027, with the BALANCE Model providing a long-term path for continued Part D coverage beyond that

2021;14:e235663

However, some doctors may prescribe it off - label for women with PCOS, particularly when insulin resistance or weight gain are major concerns